chr11-4074571-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_001382567.1(STIM1):c.861C>T(p.Arg287Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000935 in 1,614,014 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.0050   (  6   hom.,  cov: 32) 
 Exomes 𝑓:  0.00051   (  9   hom.  ) 
Consequence
 STIM1
NM_001382567.1 synonymous
NM_001382567.1 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -1.01  
Publications
0 publications found 
Genes affected
 STIM1  (HGNC:11386):  (stromal interaction molecule 1) This gene encodes a type 1 transmembrane protein that mediates Ca2+ influx after depletion of intracellular Ca2+ stores by gating of store-operated Ca2+ influx channels (SOCs). It is one of several genes located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocrotical carcinoma, and lung, ovarian, and breast cancer. This gene may play a role in malignancies and disease that involve this region, as well as early hematopoiesis, by mediating attachment to stromal cells. Mutations in this gene are associated with fatal classic Kaposi sarcoma, immunodeficiency due to defects in store-operated calcium entry (SOCE) in fibroblasts, ectodermal dysplasia and tubular aggregate myopathy. This gene is oriented in a head-to-tail configuration with the ribonucleotide reductase 1 gene (RRM1), with the 3' end of this gene situated 1.6 kb from the 5' end of the RRM1 gene. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013] 
STIM1 Gene-Disease associations (from GenCC):
- myopathy, tubular aggregate, 1Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- Stormorken syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- tubular aggregate myopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- combined immunodeficiency due to STIM1 deficiencyInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (REVEL=0.039). 
BP6
Variant 11-4074571-C-T is Benign according to our data. Variant chr11-4074571-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 461738.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=-1.01 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.005 (762/152248) while in subpopulation AFR AF = 0.0175 (728/41536). AF 95% confidence interval is 0.0165. There are 6 homozygotes in GnomAd4. There are 365 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. 
BS2
High Homozygotes in GnomAd4 at 6 AD,AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| STIM1 | NM_001382567.1 | c.861C>T | p.Arg287Arg | synonymous_variant | Exon 7 of 13 | ENST00000526596.2 | NP_001369496.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.00500  AC: 760AN: 152130Hom.:  6  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
760
AN: 
152130
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00148  AC: 370AN: 250712 AF XY:  0.00123   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
370
AN: 
250712
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.000511  AC: 747AN: 1461766Hom.:  9  Cov.: 31 AF XY:  0.000480  AC XY: 349AN XY: 727166 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
747
AN: 
1461766
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
349
AN XY: 
727166
show subpopulations 
African (AFR) 
 AF: 
AC: 
611
AN: 
33480
American (AMR) 
 AF: 
AC: 
59
AN: 
44714
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26132
East Asian (EAS) 
 AF: 
AC: 
1
AN: 
39698
South Asian (SAS) 
 AF: 
AC: 
7
AN: 
86208
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53412
Middle Eastern (MID) 
 AF: 
AC: 
4
AN: 
5762
European-Non Finnish (NFE) 
 AF: 
AC: 
8
AN: 
1111964
Other (OTH) 
 AF: 
AC: 
57
AN: 
60396
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.482 
Heterozygous variant carriers
 0 
 42 
 84 
 126 
 168 
 210 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 20 
 40 
 60 
 80 
 100 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.00500  AC: 762AN: 152248Hom.:  6  Cov.: 32 AF XY:  0.00490  AC XY: 365AN XY: 74440 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
762
AN: 
152248
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
365
AN XY: 
74440
show subpopulations 
African (AFR) 
 AF: 
AC: 
728
AN: 
41536
American (AMR) 
 AF: 
AC: 
21
AN: 
15294
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5176
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4818
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10616
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
2
AN: 
68016
Other (OTH) 
 AF: 
AC: 
11
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.495 
Heterozygous variant carriers
 0 
 36 
 72 
 108 
 144 
 180 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 10 
 20 
 30 
 40 
 50 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
5
AN: 
3478
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Benign/Likely benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:1 
Apr 15, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Myopathy with tubular aggregates;C1861451:Stormorken syndrome;C2748557:Combined immunodeficiency due to STIM1 deficiency    Benign:1 
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.